Nom du produit:tert-butyl (4R,5R)-4-allyl-5-((2S,3S)-3-(hydroxymethyl)oxiran-2-yl)-2,2-dimethyloxazolidine-3-carboxylate
IUPAC Name:tert-butyl (4R,5R)-5-[(2S,3S)-3-(hydroxymethyl)oxiran-2-yl]-2,2-dimethyl-4-(prop-2-en-1-yl)-1,3-oxazolidine-3-carboxylate
- CAS：1372800-37-7
- Formule moléculaire：C16H27NO5
- Pureté：95%+
- Numéro de catalogue：CM341635
- Poids moléculaire：313.39
| Unité d'emballage |
Stock disponible |
Prix($) |
Quantité |
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:1372800-37-7
- Formule moléculaire:C16H27NO5
- Point de fusion:-
- Code SMILES:O=C(N1C(C)(C)O[C@@H]([C@@H]2O[C@H]2CO)[C@H]1CC=C)OC(C)(C)C
- Densité:
- Numéro de catalogue:CM341635
- Poids moléculaire:313.39
- Point d'ébullition:
- N° Mdl:
- Stockage:
Category Infos
- Oxazolidines
- Oxazolidines are five-membered ring compounds consisting of three carbons, nitrogen and oxygen. Oxygen and nitrogen are in the 1 and 3 positions, respectively. Oxazolidine is in general yellow or slightly yellow, alkaline liquid or solid, easily hydrolyzed by water or alcohol. It is insoluble in water (or hydrolyzed); soluble in benzene and chloroform. Oxazolidine derivatives are five-membered cyclic compounds containing at least one oxygen and nitrogen in their molecular structure. Oxazolidine derivatives are known to possess various therapeutic activities, such as anticancer and antibiotic properties.
- Oxiranes
- Oxirane is a three-membered ring compound consisting of one oxygen atom and two carbon atoms. Oxirane is present in natural products such as cryptocin, which has anticancer properties, and azidomycin, trienone, and epoxidomycin, which have shown activity against drug-resistant leukemias and AIDS-related lymphomas. Other oxirane containing bioactive molecules have anti-inflammatory, immunosuppressive, and antitumor activities. Oxiranes are a strained ring susceptible to various nucleophilic, ring-opening or rearrangement reactions, so they are considered to be one of the most important intermediates in organic synthesis.
Recherche 
+86 21 5895 0110 
